Evidence map›Paper›PMID 40872859›Full record

ArticleViruses2025

Prevalence and Associated Factors for HPV in People Living with HIV: Are INSTIs Protective Against HPV-16? The GAIA Study.

Omar Hernández-López, Brenda Clara González-Contreras, Ana Luz Cano-Díaz, José Antonio Mata-Marín, Ericka Nelly Pompa-Mera, Javier Vicente Noyola-Gómez, Salma Triana-González, Paola Edith Padilla-Noguera, Alberto Chaparro-Sánchez, Sócrates Alberto García-Gutiérrez and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Omar Hernández-LópezInfectious Diseases Department, Hospital de Infectología "La Raza", National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
Brenda Clara González-ContrerasMedicine School, Universidad Autónoma Metropolitana, Mexico City 04960, Mexico.
Ana Luz Cano-DíazInfectious Diseases Department, Hospital de Infectología "La Raza", National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0001-9659-746X
José Antonio Mata-MarínInfectious Diseases Department, Hospital de Infectología "La Raza", National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0002-3701-9894
Ericka Nelly Pompa-MeraResearch Unit, Hospital de Infectología "La Raza", National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
Javier Vicente Noyola-GómezGynecology Department, Hospital de Infectología "La Raza", National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
Salma Triana-GonzálezInfectious Diseases Department, Hospital de Infectología "La Raza", National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0002-4175-025X
Paola Edith Padilla-NogueraMedicine School, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Mexico City 54090, Mexico.ORCID 0009-0004-0700-2081
Alberto Chaparro-SánchezInfectious Diseases Department, Hospital de Infectología "La Raza", National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0001-8480-0408
Sócrates Alberto García-GutiérrezPathology Department, Hospital de Especialidades "Dr. Antonio Fraga Mouret", "La Raza" National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
Gustavo Barriga-AnguloLaboratory Department, Hospital de Infectología "La Raza", National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
Jesús Enrique Gaytan-MartinezInfectious Diseases Department, Hospital de Infectología "La Raza", National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0003-1600-1385

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus (HPV) significantly contributes to anogenital cancers, with elevated risks among people living with HIV (PWH), particularly men who have sex with men (MSM). This study assessed anal HPV prevalence and associated risk factors in PWH in Mexico, focusing on the role of antiretroviral therapy (ART).

Indexed as

HIV InfectionsHuman papillomavirus 16Papillomavirus InfectionsAdultCross-Sectional StudiesGenotypeHomosexuality, MaleHumansMaleMexicoMiddle AgedPrevalenceRisk Factorsanal cancerantiretroviral therapyHIVHPV-16human papillomavirusINSTI

Identifiers

PMID40872859
PMCPMC12390648

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.